Here’s what we’ve been reading today:
- A Turning Point for Eminent Domain? – The NY Times “Room for Debate” forum posts the thoughts of six property law experts on the meaning of Pfizer’s decision to close its research headquarters in New London, Connecticut. New London, of course, was the epicenter of the public use case
